Medical Developments International | MVP - Cost Of Sales

Stock Price
0.42
Daily Change
0.01 2.44%
Monthly
12.00%
Yearly
-23.64%
Q2 Forecast
0.42

Medical Developments International reported AUD7.09M in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Clinuvel Pharmaceuticals AUD 2.64M 1.06M Dec/2025
Genetic Signatures AUD 6.26M 3.95M Dec/2025
Ionis Pharmaceuticals USD 3M 5M Mar/2026
Medical Developments International AUD 7.09M 4.91M Dec/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Organon & Co USD 766M 21M Dec/2025
Paradigm Biopharmaceuticals AUD 4.5K 2.62K Dec/2025
Starpharma Holdings AUD 417K 459K Dec/2025
Telix Pharmaceuticals AUD 221.36M 20.78M Dec/2025
Viatris USD 2.36B 195.9M Mar/2026
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025